Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure

Dimpi Patel, Andrea Natale, Luigi Di Biase, J. David Burkhardt, Yan Wang, Javier E. Sanchez, Rodney P. Horton, Mohammed Khan

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Atrial fibrillation (AF) and congestive heart failure (CHF) are cardiovascular epidemics. Catheter ablation of AF is increasingly performed in patients with CHF. Atrioventricular junction ablation (AVJA) and pulmonary vein isolation are the two predominant ablation strategies used to treat AF patients who are refractory to drugs. In patients with CHF refractory to drugs, AVJA with a biventricular device is associated with improvement in exercise capacity and quality of life. However, in a head-to-head comparison, pulmonary vein antrum ablation was shown to be superior to AVJA. Cure of AF in patients with CHF resulted in more significant morphological and functional improvements than AVJA.

Original languageEnglish (US)
Pages (from-to)779-787
Number of pages9
JournalExpert Review of Cardiovascular Therapy
Issue number7
StatePublished - Jul 2009
Externally publishedYes


  • Atrial fibrillation
  • Catheter ablation
  • Congestive heart failure
  • Left ventricular systolic dysfunction
  • Pulmonary vein antral isolation

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure'. Together they form a unique fingerprint.

Cite this